Alfred H. Moffett

Denosumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, E. Michael Lewiecki, Stanley Cohen et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Effect of Combined Risedronate and Hormone Replacement Therapies on Bone Mineral Density in Postmenopausal Women¹

Steven T. Harris, Erik Fink Eriksen, Michael Davidson et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 135 citations · Full text

Pharmacy, Endocrinology, Bone Metabolism +16

Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy

Chris Recknor, E. J. Czerwiński, Henry G. Bone et al. · Obstetrics and Gynecology · 2013 · 130 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

Michael R. McClung, Ethel S. Siris, Steve Cummings et al. · Menopause The Journal of The North American Menopause Society · 2006 · 110 citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

David L. Kendler, Michael R. McClung, Nick Freemantle et al. · Osteoporosis International · 2010 · 100 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +11